Our previous study in murine syngeneic tumor models demonstrated that preexisting CD4+ and CD8+ T cells against a chronic murine cytomegalovirus (MCMV) infection could be activated in a suppressive tumor immune microenvironment by intratumoral injection of cognate CD4+ and CD8+ T cell peptide epitopes19. This evidence concerns the gene CD4 and neoplasm.